THC Biomed Intl Statistics

Total Valuation

THC Biomed Intl has a market cap or net worth of 164.

Market Cap	164
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Thursday, April 2, 2026.

Earnings Date	Apr 2, 2026
Ex-Dividend Date	n/a

Share Statistics

THC Biomed Intl has 163.94 million shares outstanding.

Current Share Class	163.94M
Shares Outstanding	163.94M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	0.00
P/TBV Ratio	0.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.41, with a Debt / Equity ratio of 1.02.

Current Ratio	0.41
Quick Ratio	0.04
Debt / Equity	1.02
Debt / EBITDA	n/a
Debt / FCF	-13.43
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.47% and return on invested capital (ROIC) is -20.19%.

Return on Equity (ROE)	-56.47%
Return on Assets (ROA)	-15.27%
Return on Invested Capital (ROIC)	-20.19%
Return on Capital Employed (ROCE)	-63.86%
Weighted Average Cost of Capital (WACC)	-0.05%
Revenue Per Employee	46,939
Profits Per Employee	-77,352
Employee Count	35
Asset Turnover	0.15
Inventory Turnover	1.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.90% in the last 52 weeks. The beta is -183.14, so THC Biomed Intl's price volatility has been lower than the market average.

Beta (5Y)	-183.14
52-Week Price Change	-99.90%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	41.78
Average Volume (20 Days)	8,271

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.19

Income Statement

In the last 12 months, THC Biomed Intl had revenue of 1.64 million and -2.71 million in losses. Loss per share was -0.02.

Revenue	1.64M
Gross Profit	-856,621
Operating Income	-2.67M
Pretax Income	-2.71M
Net Income	-2.71M
EBITDA	-2.21M
EBIT	-2.67M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 151,179 in cash and 3.54 million in debt, giving a net cash position of -3.39 million or -0.02 per share.

Cash & Cash Equivalents	151,179
Total Debt	3.54M
Net Cash	-3.39M
Net Cash Per Share	-0.02
Equity (Book Value)	3.47M
Book Value Per Share	0.02
Working Capital	-3.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -280,406 and capital expenditures 16,561, giving a free cash flow of -263,845.

Operating Cash Flow	-280,406
Capital Expenditures	16,561
Free Cash Flow	-263,845
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is -52.14%, with operating and profit margins of -162.67% and -164.79%.

Gross Margin	-52.14%
Operating Margin	-162.67%
Pretax Margin	-164.79%
Profit Margin	-164.79%
EBITDA Margin	-134.30%
EBIT Margin	-162.67%
FCF Margin	n/a

Dividends & Yields

THC Biomed Intl does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.75%
Shareholder Yield	0.75%
Earnings Yield	-1,650,807.93%
FCF Yield	-160,881.10%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

THC Biomed Intl has an Altman Z-Score of -3.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.4
Piotroski F-Score	3